Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Net Cash Flow (2019 - 2025)

Outset Medical (OM) has disclosed Net Cash Flow for 7 consecutive years, with -$931000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 101.03% to -$931000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$88.5 million, a 259.46% decrease, with the full-year FY2025 number at -$88.5 million, down 259.46% from a year prior.
  • Net Cash Flow was -$931000.0 for Q4 2025 at Outset Medical, up from -$3.1 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $90.7 million in Q4 2024 to a low of -$68.0 million in Q1 2022.
  • A 5-year average of -$14.5 million and a median of -$16.1 million in 2022 define the central range for Net Cash Flow.
  • Biggest YoY gain for Net Cash Flow was 28315.0% in 2024; the steepest drop was 4924.18% in 2024.
  • Outset Medical's Net Cash Flow stood at -$48.2 million in 2021, then surged by 57.11% to -$20.7 million in 2022, then skyrocketed by 255.95% to $32.2 million in 2023, then soared by 181.66% to $90.7 million in 2024, then crashed by 101.03% to -$931000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Net Cash Flow are -$931000.0 (Q4 2025), -$3.1 million (Q3 2025), and -$36.4 million (Q2 2025).